Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland

International Journal of STD and AIDS

Volumn 24, Issue 7, 2013, Pages 561-565

  Dziuban, E J ^a,b   Marton, S A ^b   Hughey, A B ^a   Mbingo, T L ^c   Draper, H R ^a,b   Schutze, G E ^a,b  

^a Children's Hospital   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (Swaziland)

Author keywords

Africa; AIDS; coinfection; hepatitis B virus; HIV; paediatric; seroprevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROPREVALENCE; SWAZILAND;

AFRICA; AIDS; COINFECTION; HEPATITIS B VIRUS; HIV; PAEDIATRIC; SEROPREVALENCE;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SWAZILAND; VIRAL LOAD;

EID: 84887394335     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413476274     Document Type: Article

References (34)

1. Lacombe K,Bottero J,Lemoine M,et al.HIV/hepatitis B virus co-infection: current challenges and new strategies.J Antimicrob Chemother. 2010;65:10-7.
2. Lewden C,Salmon D,Morlat P,et al.Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.Int J Epidemiol. 2005;34:121-30.
3. Bica I,McGovern B,Dhar R,et al.Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.Clin Infect Dis. 2001;32:492-7.
4. Salmon-Ceron D,Lewden C,Morlat P,et al.Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.J Hepatol. 2005;42:799-805.
5. Thio CL,Seaberg EC,Skolasky R,et al.HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).Lancet. 2002;360:1921-6.
6. Thio CL.Hepatitis B and human immunodeficiency virus coinfection.Hepatology. 2009;49:S138-145.
7. Adewole OO,Anteyi E,Ajuwon Z,et al.Hepatitis B and C virus co-infection in Nigerian patients with HIV infection.J Infect Dev Ctries. 2009;3:369-75.
8. Alter MJ.Epidemiology of viral hepatitis and HIV co-infection.J Hepatol. 2006;44:S6-9.
9. Patel P,Davis S,Tolle M,et al.Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana.Am J Trop Med Hyg. 2011;85:390-4.
10. Diop-Ndiaye H,Touré-Kane C,Etard JF,et al.Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).J Med Virol. 2008;80:1332-6.
11. Nyirenda M,Beadsworth MB,Stephany P,et al.Prevalence of infection with hepatitis B and C virus and co-infection with HIV in medical inpatients in Malawi.J Infect. 2008;57:72-7.
12. WHO. Swaziland: WHO and UNICEF Estimates of National Immunization Coverage. See http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/index4.html, (last checked 15 November 2012).
13. Antiretroviral Therapy of HIV Infection in Infants and children: towards Universal Access. Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization; 2006:.
14. Modi AA,Feld JJ.Viral hepatitis and HIV in Africa.AIDS Rev. 2007;9:25-39.
15. Gomez-Gonzalo M,Carretero M,Rullas J,et al.The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.J Biol Chem. 2001;276:35435-43.
16. Chun HM,Roediger MP,Hullsiek KH,et al.Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.J Infect Dis. 2012;205:185-93.
17. Hoffmann CJ,Thio CL.Clinical implications of HIV and hepatitis B co-infection in Asia and Africa.Lancet Infect Dis. 2007;7:402-9.
18. Barth RE,Huijgen Q,Taljaard J,et al.Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis.Int J Infect Dis. 2010;14:e1024-1031.
19. Rouet F,Chaix ML,Inwoley A,et al.Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.Clin Infect Dis. 2008;46:361-6.
20. Ashir GM,Rabasa AI,Gofama MM,et al.Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection.Niger J Med. 2009;18:260-2.
21. Chakraborty R,Rees G,Bourboulia D,et al.Viral coinfections among African children infected with human immunodeficiency virus type 1.Clin Infect Dis. 2003;36:922-4.
22. Immunization Summary. A Statistical Reference Containing Data Through 2009. New York, NY: The United Nations Children's Fund; 2011:.
23. Psevdos G,Kim JH,Suh JS,et al.Predictors of loss of hepatitis B surface antigen in HIV-infected patients.World J Gastroenterol. 2010;16:1093-6.
24. Bwogi J,Braka F,Makumbi I,et al.Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.Afr Health Sci. 2009;9:98-108.
25. Ott JJ,Stevens GA,Groeger J,et al.Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.Vaccine. 2012;30:2212-9.
26. Management of Hepatitis B and HIV Coinfection. Clinical Protocol for the WHO European Region. Copenhagen, Denmark: World Health Organization; 2011:.
27. Idoko J,Meloni S,Muazu M,et al.Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.Clin Infect Dis. 2009;49:1268-73.
28. lsa SE,Gwamzhi LN,Akolo C,et al.A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.Niger J Med. 2010;19:279-85.
29. Jobarteh M,Malfroy M,Peterson I,et al.Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.Virol J. 2010;7:230.
30. Eke AC,Eke UA,Okafor CI,et al.Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting.Virol J. 2011;8:12.
31. Lim SG,Wai CT,Rajnakova A,et al.Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.Gut. 2002;51:597-9.
32. Peters PJ,Marston BJ.Preventing deaths in persons with HIV/hepatitis B virus coinfection: a call to accelerate prevention and treatment efforts.J Infect Dis. 2012;205:166-8.
33. National Guidelines on the Comprehensive HIV Package of Care for Adults and Adolescents in Swaziland. Mbabane, Swaziland: Swaziland Ministry of Health; 2010:.
34. Use of tenofovir in HIV-infected Children and Adolescents: A public health perspective. Geneva, Switzerland:: World Health Organization; 2012:.